Bone Biologics Corp (BBLGW) Return on Assets (2013 - 2025)
Bone Biologics (BBLGW) posted quarterly Return on Assets of 0.01% for Q4 2025, up 1.0% year-over-year from 0.01% in Q4 2024, and up 11.8% quarter-over-quarter from 0.01% in Q3 2025.
Bone Biologics Corp (BBLGW) Return on Assets (2013 - 2025) Analysis & Trends
Bone Biologics (BBLGW) has reported Return on Assets for 13 consecutive years, with 0.01% the latest figure, recorded in Q4 2025.
- In Q4 2025, Return on Assets rose 1.0% year-over-year to 0.01%; the TTM figure through Dec 2025 stood at 0.01% (up 1.0% YoY), while the FY2025 annual figure was 0.06%, up 1.0% from the prior year.
- Return on Assets climbed to 0.01% in Q4 2025 per BBLGW's latest filing, from 0.01% in the prior quarter.
- Across five years, Return on Assets topped out at 0.0% in Q1 2022 and bottomed at 0.66% in Q3 2021.
- Historically, Return on Assets has averaged 0.09% across 5 years, with a median of 0.03% in 2023.
- Annual changes were most pronounced in 2021 — Return on Assets soared 911 bps — and 2023, when it decreased 4 bps.
- Bone Biologics' Return on Assets stood at 0.0% in 2021, then plunged by 632 bps to 0.04% in 2022, then tumbled by 96 bps to 0.07% in 2023, then jumped by 84 bps to 0.01% in 2024, then soared by 48 bps to 0.01% in 2025.
- Business Quant data shows BBLGW's Return on Assets at 0.01% in Q4 2025, 0.01% in Q3 2025, and 0.01% in Q2 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.07% |
| Jun 30, 2024 | -0.07% |
| Mar 31, 2024 | -0.07% |
| Dec 31, 2023 | -0.07% |
| Sep 30, 2023 | -0.05% |
| Jun 30, 2023 | -0.04% |
| Mar 31, 2023 | -0.03% |
| Dec 31, 2022 | -0.04% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | -0.66% |
| Jun 30, 2021 | -0.47% |
| Sep 30, 2020 | -9.77% |